Pharmacy-based infectious disease management programs incorporating CLIA-waived point-of-care tests

S. R. Herbin, D. G. Klepser, M. E. Klepser

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

There are roughly 48,000 deaths caused by influenza annually and an estimated 200,000 people who have undiagnosed human immunodeficiency virus (HIV). These are examples of acute and chronic illnesses that can be identified by employing a CLIA-waived test. Pharmacies across the country have been incorporating CLIA-waived point-of-care tests (POCT) into disease screening and management programs offered in the pharmacy. The rationale behind these programs is discussed. Additionally, a summary of clinical data for some of these programs in the infectious disease arena is provided. Finally, we discuss the future potential for CLIAwaived POCT-based programs in community pharmacies.

Original languageEnglish (US)
Article numbere00726
JournalJournal of clinical microbiology
Volume58
Issue number5
DOIs
StatePublished - May 2020

Keywords

  • CLIA waived
  • POCT
  • Pharmacy
  • Point-of-care

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Pharmacy-based infectious disease management programs incorporating CLIA-waived point-of-care tests'. Together they form a unique fingerprint.

Cite this